IQVIA Holdings Inc.

Healthcare · Medical - Diagnostics & Research

Overall research band Mixed

Quality Mixed

Valuation Strong

Balance sheet Very weak

Market confirmation Exceptional

One-minute company read

What this report can tell you now

What the company does

IQVIA Holdings Inc. is a global provider of analytical insights, advanced technology solutions, and clinical research services for the life sciences industry, operating across the Americas, Europe, Africa, and Asia-Pacific. The company is organized into three main divisions: Technology & Analytics Solutions, which offers cloud-native applications, real-world data solutions, consulting, analytics, and commercial process outsourcing; Research & Development Solutions, which delivers clinical trial management, monitoring, virtual trial capabilities, and laboratory services including genomic and biomarker analyses; and Contract Sales & Medical Solutions, which engages healthcare professionals and patients and provides scientific strategy and medical affairs support. IQVIA serves pharmaceutical, biotechnology, medical device, diagnostic, and consumer health companies, generating revenue through the provision of these technology, data, consulting, and research services.

The current research profile is Mixed Setup, with elevated leverage. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

Read the latest filing or company update.
Check the financial period behind each metric.
Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC9.8%Model input; read with the evidence status and period context.

Operating margin14.0%Model input; read with the evidence status and period context.

Revenue CAGR · 4 years4.1%Model input; read with the evidence status and period context.

FCF margin12.6%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.

Evidence detailSee exact inputs, source context, and model-aware metrics.

HistoryReview score and research changes over time.

MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.